Skip to main content
OpenTrials

Clinical trial condition

Fatty Liver

Explore clinical trials studying Fatty Liver. Study availability and eligibility vary by location and protocol.

437 public trials 78 recruiting studies
Refine in advanced search Browse all conditions

Fatty Liver trial results

Recruiting

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

NCT07718126

Conditions
Digestive System Diseases, Fatty Liver, Hepatic Steatosis, +3 more
Locations
  • Anhui Provincial Hospital (The First Affiliated Hospital of USTC) Hefei, Anhui, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • West China Hospital, Sichuan University Chengdu, Sichuan, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View Trial Details
Recruiting

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07704892

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +4 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Springboro, Ohio, United States
View Trial Details
Recruiting

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

NCT07701993

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +4 more
Locations
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Humble, Texas, United States
  • GSK Investigational Site San Antonio, Texas, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

NCT06419374

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +7 more
Locations
  • 89bio Clinical Study Site Birmingham, Alabama, United States
  • 89bio Clinical Study Site Homewood, Alabama, United States
  • 89bio Clinical Study Site Chandler, Arizona, United States
  • 89bio Clinical Study Site Flagstaff, Arizona, United States
View all 326 locations
View Trial Details
Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

NCT06318169

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +7 more
Locations
  • 89bio Clinical Study Site Birmingham, Alabama, United States
  • 89bio Clinical Study Site Chandler, Arizona, United States
  • 89bio Clinical Study Site Flagstaff, Arizona, United States
  • 89bio Clinical Study Site Glendale, Arizona, United States
View all 367 locations
View Trial Details

Related conditions